|
|
Presentations
| All presentations are posted in PDF format.
If your browser is not equipped with the Adobe Reader - Click
Here - to obtain and install
it. |
 |
|
| 2008 |
8/20/08 |
Antinociceptive Response of the Local Anesthetic TQ-1019 in the Radiant Heat Tail-Flick Assay. World Congress on Pain, August 20, 2008, Glasgow, Scotland. |
| |
8/20/08 |
Antinociceptive Effects of the Local Anesthetic TQ-1019 in a Combined ddC/gp120 Model of Painful HIV Neuropathy. World Congress on Pain, August 20, 2008, Glasgow, Scotland.
|
| |
8/20/08 |
Response to the Local Anesthetic TQ-1019 in the GP120 Model of Painful HIV Neuropathy. World Congress on Pain, August 20, 2008, Glasgow, Scotland.
|
| |
8/20/08 |
Novel Abuse Deterrent Extended Release SECUREL™ Dosage Forms of Tramadol. World Congress on Pain, August 20, 2008, Glasgow, Scotland. |
| 2006 |
11/7/06 |
Rodman & Renshaw 8th Annual Healthcare Conference. November 7, 2006, New York. |
| 2005 |
8/24/05 |
Co-administration
of TQ-1016 and Morphine in the Rat Tail-flick Assay: Evidence
of a Synergistic
Interaction. 11th World Congress
on Pain, August 24, 2005, Sydney, Australia. |
| |
8/24/05 |
Effects
of the Opioid Agonist TQ-1015 on Carrageenan-induced Inflammation. 11th
World Congress on Pain, August 24, 2005, Sydney, Australia. |
| |
8/24/05 |
The
Opioid Agonist TQ-1015 is Active in the Hotplate Assay
of Nociception. 11th World Congress on Pain, August
24, 2005, Sydney, Australia. |
| |
8/24/05 |
Dose-dependent
Antinociceptive Effects of the Opioid Agonist TQ-1015 in
the Rat Tail-flick Assay. 11th World Congress on
Pain, August 24, 2005, Sydney, Australia. |
| |
8/22/05 |
Efficacy
of Intravenous TQ-1011 in Moderate to Severe Postsurgical
Pain: A Randomized,
Placebo and Active Controlled Study. 11th
World Congress on Pain, August 22, 2005, Sydney, Australia. |
| |
4/1/05 |
The Opioid Agonist TQ-1015 Reverses Mechanical Allodynia
and Thermal Hyperalgesia
in Carrageenan-induced Inflammation.
24th Annual Scientific
Meeting of the American Pain Society, March 30-April 2, 2005,
Boston, Massachusetts. |
| |
3/31/05 |
Albuterol (TQ-1016) Enhances the Analgesic Effects of Morphine
in the Rat Tail-flick Assay.
24th Annual Scientific Meeting
of the American Pain Society, March 30-April 2, 2005, Boston,
Massachusetts. |
| |
3-30-05 |
Intravenous Ketoprofen (TQ-1011) is Superior to Morphine
and Placebo in Alleviating Moderate to Severe Postsurgical
Pain.
Annual Scientific Meeting of the American Pain Society,
March 30-April 2, 2005, Boston, Massachusetts. |
|
| 2003 |
8-17-02 |
Efficacy of Commonly Used Pharmacologic
Agents in Neuropathic Pain. 10th World Congress on Pain, August 17-22, 2002, San
Diego, California. |
| |
6-12-03 |
Current
Regulatory Initiatives in Analgesia.
SMi Pain
Therapeutics Conference, June 12, 2003, London, UK. |
| |
3-20-03 |
Chronic
Pain Sleep Inventory for Evaluation of Treatment Responses
to Opioid Analgesics: Randomized, Placebo Controlled Clinical
Trials in OA.
22nd Annual Scientific Meeting of the
American Pain Society, March 20-23, 2003, Chicago, Illinois. |
|
| 2002 |
7-30-02 |
Multi-dose
Analgesic Drug Development in Acute Pain.
Presentation
to the FDA Arthritis Advisory Committee Meeting, July 30, 2002,
Bethesda, Maryland |
| |
7-29-02 |
Analgesic
Drug Development for Chronic Pain.
Presentation
to the FDA Arthritis Advisory Committee Meeting, July 29, 2002,
Bethesda, Maryland. |
| |
5-16-02 |
Analgesic Drug
Development for Neuropathic Pain.
Presentation to the
FDA Anesthetic Life Support Drug Advisory Committee, May 16,
2002, Bethesda, Maryland. |
| |
3-24-02 |
Symptom
Characteristics of Patients in Randomized Clinical Trials
in Cancer Pain.
103rd Annual Meeting of the American
Society for Clinical Pharmacology and Therapeutics, March 24-27,
2002, Atlanta, Georgia. |
| |
3-24-02 |
Treatment
Effects of Pharmacologic Agents on Key Outcome Variables
in Osteoarthritis.
103rd Annual Meeting of the American
Society for Clinical Pharmacology and Therapeutics, March 24-27,
2002, Atlanta, Georgia. |
|
|
